George A. Călin

6 ta ish

The University of Texas MD Anderson Cancer Center

1. Targeting non-coding RNAs to overcome cancer therapy resistance

   Baoqing Chen, Mihnea P. Dragomir, Yang Chen +3

   Sharh maqolaOAOchiq kirish20224 iqtibos

   ABIABI:AkademIndex/2026.other.003230

2. Noncoding RNA therapeutics — challenges and potential solutions

   Melanie Winkle, Sherien M. El‐Daly, Muller Fabbri +1

   Sharh maqolaOAOchiq kirish20214 iqtibos

   ABIABI:AkademIndex/2026.other.224124

3. Going circular: history, present, and future of circRNAs in cancer

   Giuseppina Pisignano, David C. Michael, Tanvi H. Visal +3

   Sharh maqola20233 iqtibos

   ABIABI:AkademIndex/2026.other.442029

4. Targeting microRNAs as key modulators of tumor immune response

   Laura Paladini, Linda Fabris, Giulia Bottai +3

   Sharh maqolaOAOchiq kirish20162 iqtibos

   ABIABI:AkademIndex/2026.other.235600

5. Exosomal Non-Coding RNAs: Diagnostic, Prognostic and Therapeutic Applications in Cancer

   Marc D. Bullock, Andreia Silva, Pinar Kanlikilicer-Unaldi +5

   Sharh maqolaOAOchiq kirish20152 iqtibos

   ABIABI:AkademIndex/2026.other.247207

6. <i>CCAT2</i>, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer

   Hui Ling, Riccardo Spizzo, Yaser Atlasi +50

   Maqola20132 iqtibos

   ABIABI:AkademIndex/2026.other.472408